Stay updated on Pancreatic Cancer Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Pancreatic Cancer Immunotherapy Clinical Trial page.

Latest updates to the Pancreatic Cancer Immunotherapy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe clinical trial record for locally advanced pancreatic cancer is now displayed, with study design, participant eligibility, treatment details, outcome measures, and results information.SummaryDifference65%

- Check15 days agoChange DetectedThe ClinicalTrials.gov page continues to display a 403 Forbidden error instead of the study record. Its footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe footer now displays revision v3.7.2 instead of v3.7.1 on the page showing a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record. This indicates access to the study details is blocked.SummaryDifference0.5%

Stay in the know with updates to Pancreatic Cancer Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pancreatic Cancer Immunotherapy Clinical Trial page.